190 related articles for article (PubMed ID: 16875934)
1. The I1307K APC polymorphism in Ashkenazi Jews with colorectal cancer: clinical and pathologic features.
Locker GY; Kaul K; Weinberg DS; Gatalica Z; Gong G; Peterman A; Lynch J; Klatzco L; Olopade OI; Bomzer CA; Newlin A; Keenan E; Tajuddin M; Knezetic J; Coronel S; Lynch HT
Cancer Genet Cytogenet; 2006 Aug; 169(1):33-8. PubMed ID: 16875934
[TBL] [Abstract][Full Text] [Related]
2. The I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian cancer kindreds.
Petrukhin L; Dangel J; Vanderveer L; Costalas J; Bellacosa A; Grana G; Daly M; Godwin AK
Cancer Res; 1997 Dec; 57(24):5480-4. PubMed ID: 9407954
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms.
Zauber NP; Sabbath-Solitare M; Marotta S; Zauber AG; Foulkes W; Chan M; Turner F; Bishop DT
Cancer; 2005 Aug; 104(4):719-29. PubMed ID: 15959913
[TBL] [Abstract][Full Text] [Related]
4. The I1307K adenomatous polyposis coli gene variant does not contribute in the assessment of the risk for colorectal cancer in Ashkenazi Jews.
Strul H; Barenboim E; Leshno M; Gartner M; Kariv R; Aljadeff E; Aljadeff Y; Kazanov D; Strier L; Keidar A; Knaani Y; Degani Y; Alon-Baron L; Sobol-Dvory H; Halpern Z; Arber N
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1012-5. PubMed ID: 14578136
[TBL] [Abstract][Full Text] [Related]
5. The APC p.I1307K polymorphism is a significant risk factor for CRC in average risk Ashkenazi Jews.
Boursi B; Sella T; Liberman E; Shapira S; David M; Kazanov D; Arber N; Kraus S
Eur J Cancer; 2013 Nov; 49(17):3680-5. PubMed ID: 23896379
[TBL] [Abstract][Full Text] [Related]
6. Adenomatous polyposis coli I1307K mutation in Jewish patients with different ethnicity: prevalence and phenotype.
Drucker L; Shpilberg O; Neumann A; Shapira J; Stackievicz R; Beyth Y; Yarkoni S
Cancer; 2000 Feb; 88(4):755-60. PubMed ID: 10679643
[TBL] [Abstract][Full Text] [Related]
7. No association of the I1307K APC allele with ovarian cancer risk in Ashkenazi Jews.
Abrahamson J; Moslehi R; Vesprini D; Karlan B; Fishman D; Smotkin D; Ben David Y; Biran H; Fields A; Brunet JS; Narod SA
Cancer Res; 1998 Jul; 58(14):2919-22. PubMed ID: 9679945
[TBL] [Abstract][Full Text] [Related]
8. The effect of the I1307K APC polymorphism on the clinicopathological features and natural history of breast cancer.
Yuan ZQ; Bégin LR; Wong N; Brunet JS; Trifiro M; Gordon PH; Pinsky L; Foulkes WD
Br J Cancer; 1999 Nov; 81(5):850-4. PubMed ID: 10555757
[TBL] [Abstract][Full Text] [Related]
9. How the I1307K adenomatous polyposis coli gene variant contributes in the assessment of risk of colorectal cancer, but not stomach cancer, in a Turkish population.
Dundar M; Caglayan AO; Saatci C; Karaca H; Baskol M; Tahiri S; Ozkul Y
Cancer Genet Cytogenet; 2007 Sep; 177(2):95-7. PubMed ID: 17854661
[TBL] [Abstract][Full Text] [Related]
10. The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews.
Woodage T; King SM; Wacholder S; Hartge P; Struewing JP; McAdams M; Laken SJ; Tucker MA; Brody LC
Nat Genet; 1998 Sep; 20(1):62-5. PubMed ID: 9731533
[TBL] [Abstract][Full Text] [Related]
11. The characterization of somatic APC mutations in colonic adenomas and carcinomas in Ashkenazi Jews with the APC I1307K variant using linkage disequilibrium.
Zauber NP; Sabbath-Solitare M; Marotta SP; Bishop DT
J Pathol; 2003 Feb; 199(2):146-51. PubMed ID: 12533826
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic characteristics associated with the APC gene I1307K mutation in Ashkenazi Jewish patients with colorectal polyps.
Syngal S; Schrag D; Falchuk M; Tung N; Farraye FA; Chung D; Wright M; Whetsell A; Miller G; Garber JE
JAMA; 2000 Aug; 284(7):857-60. PubMed ID: 10938175
[TBL] [Abstract][Full Text] [Related]
13. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.
Shtoyerman-Chen R; Friedman E; Figer A; Carmel M; Patael Y; Rath P; Fidder HH; Bar-Meir S; Theodor L
Genet Test; 2001; 5(2):141-6. PubMed ID: 11551102
[TBL] [Abstract][Full Text] [Related]
14. Genetic analyses in consecutive israeli jewish colorectal cancer patients.
Fidder HH; Figer A; Geva R; Flex D; Schayek H; Avidan B; Meir SB; Friedman E
Am J Gastroenterol; 2005 Jun; 100(6):1376-80. PubMed ID: 15929773
[TBL] [Abstract][Full Text] [Related]
15. Clinical and screening implications of the I1307K adenomatous polyposis coli gene variant in Israeli Ashkenazi Jews with familial colorectal neoplasia. Evidence for a founder effect.
Rozen P; Naiman T; Strul H; Taussky P; Karminsky N; Shomrat R; Samuel Z; Yaron Y; Orr-Urtreger A
Cancer; 2002 May; 94(10):2561-8. PubMed ID: 12173321
[TBL] [Abstract][Full Text] [Related]
16. APC I1307K increases risk of transition from polyp to colorectal carcinoma in Ashkenazi Jews.
Stern HS; Viertelhausen S; Hunter AG; O'Rourke K; Cappelli M; Perras H; Serfas K; Blumenthall A; Dewar D; Baumann E; Lagarde AE
Gastroenterology; 2001 Feb; 120(2):392-400. PubMed ID: 11159880
[TBL] [Abstract][Full Text] [Related]
17. Somatic instability of the APC I1307K allele in colorectal neoplasia.
Gryfe R; Di Nicola N; Gallinger S; Redston M
Cancer Res; 1998 Sep; 58(18):4040-3. PubMed ID: 9751605
[TBL] [Abstract][Full Text] [Related]
18. Colorectal tumourigenesis in carriers of the APC I1307K variant: lone gunman or conspiracy?
Sieber O; Lipton L; Heinimann K; Tomlinson I
J Pathol; 2003 Feb; 199(2):137-9. PubMed ID: 12533824
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic cases.
Figer A; Shtoyerman-Chen R; Tamir A; Geva R; Irmin L; Flex D; Theodor L; Sulkes A; Sadetzki S; Bar-Meir S; Friedman E
Br J Cancer; 2001 Nov; 85(9):1368-71. PubMed ID: 11720476
[TBL] [Abstract][Full Text] [Related]
20. Low prevalence of the APC I1307K sequence in Jewish and non-Jewish patients with inflammatory bowel disease.
Yin J; Harpaz N; Souza RF; Zou T; Kong D; Wang S; Leytin AL; Medalie NS; Smolinski KN; Abraham JM; Fleisher AS; Meltzer SJ
Oncogene; 1999 Jul; 18(26):3902-4. PubMed ID: 10445854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
